• Join
  • Login
  • Contact

Search abstracts

Risk of cardiovascular disease and all-cause mortality among diabetes patients prescribed rosiglitazone or pioglitazone: a meta-analysis of retrospective cohort studies

  • In: Individualised Medicine Posters
  • At: Hyderabad (India) (2011)
  • Type: Poster
  • Poster code: IM-P-07
  • By: YANG, Li (Peking University Third Hospital, Beijing, China)
  • Co-author(s): Chen, Xin (Peking University Third Hospital, Beijing, China)
    Zhai, Suodi (Peking University Third Hospital, Beijing, China)
  • Abstract:

    Objective: To determine the risk of cardiovascular adverse effects in patients with type 2 diabetes treated with rosiglitazone compared to pioglitazone.
    Design: Meta-analysis of retrospective cohort studies using RevMan 5.0 software to calculate risk ratios.
    Data sources: The Cochrane Library, PubMed, and Embase were searched to identify relevant


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses